UN Health News

Access to a new COVID-19 drug will be expanded in low- and middle-income countries following a voluntary licensing agreement between the pharmaceutical company Pfizer and a UN-backed global health initiative, announced in Geneva on Tuesday.

Efforts to boost COVID-19 vaccine production should be matched by access to the syringes needed to inject them - and there could even be a global shortage of needles for regular immunization campaigns next year - the World Health Organization (WHO)

About 22 months since the first cases of COVID-19 were reported, and almost a year since the first vaccines were approved, reported cases and deaths from the virus are increasing again.

Deaths from tuberculosis – one of the top infectious killers in the world - have increased for the first time in a decade, as a direct result of the COVID-19 pandemic, the World Health Organization (WHO) said on Thursday.

Although COVID-19 deaths continue to decline, vaccine inequity persists, the head of the World Health Organization (WHO) said on Wednesday, again calling for greater support for developing countries.

The UN World Health Organization (WHO) on Thursday unveiled an $8 billion pathway out of the COVID-19 pandemic, in a bid to make vaccines accessible to everyone, everywhere.

The number of COVID-19 cases and deaths has continued to decline globally, with  3.1 million new cases and just over 54,000 new deaths, reported over the last week, according to the World Health Organization (WHO).

Top politicians joined award-winning African performers and others on Tuesday, in New York, to take part in a special event organized by the UN Development Programme (UNDP), to discuss how COVID-19 vaccines can be fairly distributed worldwide, as a

While 80 per cent of citizens in high and upper-middle income nations have had a dose of COVID-19 vaccine, that figure stands at just 20 per cent for those living below the top tiers, according to a joint statement issued by UN and partner agencies

Even with the emergence of the new Mu COVID-19 variant, the Delta strain remains the top concern globally, appearing to “outcompete” others, senior officials with the World Health Organization (WHO) said on Tuesday.